Why the study?
Does everolimus-eluting stent placement reduce side branch occlusion and periprocedural myocardial infarction compared to paclitaxel-eluting stent placement?
Does everolimus-eluting stent placement reduce side branch occlusion and periprocedural myocardial infarction compared to paclitaxel-eluting stent placement?
Answers are grounded in this paper and cite their sources.
Everolimus-eluting stents are associated with a significantly lower risk of side branch occlusion and subsequent periprocedural non-Q-wave myocardial infarction compared to paclitaxel-eluting stents.
AIMS AND METHODS: The rates of side branch occlusion and subsequent periprocedural MI during everolimus-eluting stent (EES) and paclitaxel-eluting stent (PES) placement were examined in the randomised SPIRIT III trial. Periprocedural myocardial infarction (MI) following drug-eluting stent placement is associated with long-term adverse outcomes. Occlusion of side branches may be an important factor contributing to periprocedural MIs. Consecutive procedural angiograms of patients randomly assigned to EES (n=669) or PES (n=333) were analysed by an independent angiographic core laboratory. Side branch occlusion was defined as Thrombolysis In Myocardial Infarction (TIMI) flow grade 0 or 1. Clinical outcomes through three years were compared by stent type and presence of side branch occlusion. CONCLUSIONS: A total of 2,048 side branches were evaluated (EES N=1,345 side branches in 688 stented lesions, PES N=703 side branches in 346 stented lesions). Patients with compared to those without transient or final side branch occlusion had significantly higher non-Q-wave MI (NQMI) rates in-hospital (9.0% vs. 0.5%, p<0.0001). By multivariable analysis side branch occlusion was an independent predictor of NQMI (OR 4.45; 95% CI [1.82, 10.85]). Transient or final side branch occlusion occurred less frequently in patients receiving EES compared to PES (2.8% vs. 5.2%, p=0.009), contributing to the numerically lower rates of in-hospital NQMI with EES arm compared to PES (0.7% vs. 2.3%, p=0.05). Patients treated with EES rather than PES were less likely to develop side branch occlusion during stent placement, contributing to lower rates of periprocedural MI with EES compared to PES.
No takes yet. Share an insight, caveat, or question.
Lansky et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: